- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- May 05, 2024, 07:06:24 AM
- Local Time:
- May 24, 2024, 09:41:36 AM
- Last Active:
- May 05, 2024, 08:55:28 AM
Signature:
Even though utilization of PARP inhibitors is a large step forward, it is apparent which patients, equally with along with without BRCA-mutant ovarian